Lp(a) Reduction, GLP-1s for Heart Failure, and More-Highlights From the AHA Scientific Sessions.

JAMA

Director, Medical News & Perspectives, JAMA.

Published: December 2024

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2024.21051DOI Listing

Publication Analysis

Top Keywords

lpa reduction
4
reduction glp-1s
4
glp-1s heart
4
heart failure
4
failure more-highlights
4
more-highlights aha
4
aha scientific
4
scientific sessions
4
lpa
1
glp-1s
1

Similar Publications

Lipoprotein(a) [Lp(a)] is a well-established cardiovascular disease (CVD) risk factor with elevated Lp(a) levels contributing to a higher incidence of atherosclerotic CVD (ASCVD). However, no Lp(a)-specific interventions are currently available in the primary CVD prevention in individuals with elevated Lp(a) levels. RNA-based therapies targeting Lp(a) are under investigation in phase III clinical trials.

View Article and Find Full Text PDF
Article Synopsis
  • Atherosclerotic cardiovascular disease (ASCVD) is a major global health issue, with high levels of low-density lipoprotein cholesterol (LDL-C) linked to increased cardiovascular risk.
  • Numerous studies confirm that lipid-lowering therapies (LLT) are effective; however, there is a gap between guidelines and actual clinical practice regarding LDL-C targets.
  • The review suggests new strategies beyond traditional LDL-C management, such as combination therapies and emerging drugs, while also introducing the potential use of polygenic risk scores for personalized treatment approaches in ASCVD prevention.
View Article and Find Full Text PDF

Stroke is one of the leading causes of death in developing countries, and China bears the largest global burden of stroke. This study aims to investigate the relationship between different dimensions of physical activity levels and stroke risk using a nationally representative database. We performed a cross-sectional analysis using data from the China Health and Retirement Longitudinal Study (CHARLS) 2020.

View Article and Find Full Text PDF

Purpose: An accurate assessment of time spent in 24-hour movement behaviors (24 h-MBs) is crucial in exploring health related associations. This study aims to evaluate the concurrent validity of the Daily Activity Behavior Questionnaire (DABQ) compared to the ActiGraph using absolute and relative indicators of validity.

Methods: This cross-sectional observational study included 105 adults (45 ± 13 y/o, 54% female).

View Article and Find Full Text PDF

Introduction: Hypertension is recognized as a modifiable risk factor for cardiovascular diseases, alongside dyslipidemia. Studies have revealed that between 15% to 31% of individuals have both hypertension and dyslipidemia. However, emerging evidence suggests that natural therapies and yoga can help manage mild increases in blood pressure.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!